Steris (STE) Price to Sales (2018 - 2026)

Steris has reported Price to Sales for 9 years, with the latest figure at 13.75 in Q2 2026.

• On a quarterly basis, Price to Sales fell 19.14% year-over-year to 13.75 in Q2 2026; TTM through Jun 2026 was 3.4, a 19.94% decrease from a year earlier, with the FY2026 full-year figure at 3.64, down 10.72% from the prior year.
• Price to Sales was 13.75 for Q2 2026 at Steris, up from 13.62 in the prior quarter.
• The five-year high for Price to Sales was 19.98 in Q1 2022, with the low at 13.62 in Q1 2026.
• Average Price to Sales over 5 years is 16.51, with a median of 16.62 recorded in 2025.
• The largest YoY upside for Price to Sales was 15.01% in 2023 against a maximum downside of 26.32% in 2023.
• Over 5 years, Price to Sales stood at 16.5 in 2022, then rose by 1.43% to 16.74 in 2023, then dropped by 11.98% to 14.73 in 2024, then rose by 12.81% to 16.62 in 2025, then slipped by 17.26% to 13.75 in 2026.
• The last three Price to Sales figures came in at 13.75 (Q2 2026), 13.62 (Q1 2026), and 16.62 (Q4 2025), per Business Quant data.